Bioprogress is a stock I have been in and out of quite a few times since it floated in May but not much mention here on the Investors' Room. Does anyone else follow this stock. I see it is up 1.5p today and a few good buyers seem to have appeared.

aimtrader - 14 Apr'05 - 21:45 - 1920 of 1937 edit


i think there will be further bad news, bit risky buying now i reckon...

i'm waiting for now...maybe a better entry point later



Well i seem to have called that one right!!!

Dil,
How much did you loose going short on that share with no deal, what was it's name ? Oh, yes SEO.

errr scuse me dipstick ... when did I ever say I shorted SEO ?

Your silence speaks volumes , next time try thinking before putting your foot in your gob.

.

Charmant Dil.

Well Dill.


If I am reading the following correctly, there seems to be some institutional buying. (4.950,000 Shares)( It doesn't show price. I checked that Sharescope did not list Fidelity International as share holders prior to to-day. But I wish sometimes the bulletins would be a little more understandable.

I guess there is still some life in this "dog" yet.

BioProgress PLC
27 April 2005

SCHEDULE 10

NOTIFICATION OF MAJOR INTERESTS IN SHARES


1. Name of company

Bioprogress plc

2. Name of shareholder having a major interest

Fidelity International Limited

3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above
or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18.

As above

4. Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them
172,688 Brown Brothers Harriman Lux
4,777,312 Mellon Bank N.A.

5. Number of shares/amount of stock acquired

Not disclosed

6. Percentage of issued class

Not disclosed

7. Number of shares/amount of stock disposed

Not disclosed

8. Percentage of issued class

Not disclosed

9. Class of security

Ordinary shares of 1p each

10. Date of transaction

Not disclosed

11. Date company informed

25 April 2005

12. Total holding following this notification

4.950,000

13. Total percentage holding of issued class following this notification

4.2%

14. Any additional information

15. Name of contact and telephone number for queries

Elizabeth Edwards, 01354 655674

16. Name and signature of authorised company official responsible for making this notification.

Elizabeth Edwards, Company Secretary

Date of notification: 27 April 2005




This information is provided by RNS
The company news service from the London Stock Exchange

Fred , ignore who or what is buying and whether the 1,000,000 is a buy or sell etc and concentrate on the price action.

That imo is the best indicator and I still don't think we have seen the bottom.

Not before time, Graham Hind kicked out without a thank you in sight!

http://moneyam.uk-wire.com/cgi-bin/articles/200504291405017340L.html

Dil Partially agree, but like to see volume and price up before I buy or sometimes opposite when I sell. Also prefer more than two birds in the bush.
I think that BPRG are trying to sort themselves out, but still would like to know what the real problems are. I am glad they have about 14Million is cash (I think and hope that this is so.) For now I am holding a few more than I wish I had and accept it is a Punt. (My favourite Kick.) Below just announced:

BioProgress PLC
29 April 2005


Press Release 29 April 2005


BioProgress plc

('BioProgress' or 'the Company')

Director Change


BioProgress plc (AIM: BPRG; NASDAQ: BPRG), announces that Graham Hind has today
resigned as Chief Executive Officer and Director of BioProgress.

The Company has appointed Richard Trevillion, currently a Non-Executive
Director, to act as interim Chief Executive Officer.

Richard Trevillion joined the Board in February 2005. He is the founder and CEO
of Amity Partners Limited, a principal healthcare and technology finance
business which has been responsible for numerous transactions since it was
formed in late 2002. A qualified solicitor, Mr Trevillion began his career with
law firms Lovell White Durrant and Simmons & Simmons, before moving to corporate
finance where his senior experience includes being co-Director at Arthur
Andersen responsible for their healthcare corporate finance team. Mr Trevillion
then became Head of Healthcare within the technology corporate finance group at
Close Brothers Corporate Finance in 2000.

The strategic and financial review, which the Board announced on 13 April 2005,
is continuing.

Good luck Fred , think they may uncover some more crap before the "strategic review" is completed.

Ideal time to blame everything on the old management and bung a load of write offs into the accounts and start with a clean slate.

Inclined to agree with you. Mangements are like Politicians - all smiles when it's going well, but a whif of wrongdoing and the knives are out. When the sp recovers the new management will claim all the credit, yet it is their attack on GH that is causing many to sell.
The Rewiew promised soon will also be a time to watch how the Management is to be trusted. GH will no doubt be blamed for things that he never touched, but that's the price these very-well-paid Directors have to accept.
Maybe now we can see some Contracts and follow-thro' sales - a regular income would do wonders for the sp. - but I suspect we'll see lower sp before too long. I hold for now, just hopt the Review is balanced and forward-looking.......oh deary me.

Seems to me that GH might have run out of his credit card limits and may have been drawing cash from company. LOL

So you will not see much left of 14M cash

You seem to know him well,............. think I know who you are>

ttt

Just catching up.

You haven't missed much Al , still a crock of sh*te ... 22p next stop.

22p? You're an optimist, Dil. ;-))))

I've got 15p pencilled in if we see a couple of closes below 30p. 25p looks a fairly immediate target for sure. On the fundie front, there's gonna be a few more "bad news bear stories" popping up before she's a good investment methinks.

You may be right. Are you shorting it. I wouldn't.

Fred

Not short, but would certainly consider it if the above crops up. Really don't think we've seen all the pain here now. It's unfortunate for many, but such is life.

I did when it bounced up to 45p , closed a couple of weeks ago.

Next leg down starting , uncertainty over the ongoing "strategic review" aint helping the share price.